Holdings
Goldman Sachs Future Health Care Equity ETF
As of May 31, 2026, Goldman Sachs Future Health Care Equity ETF reported 40 positions worth US$19.8M. Largest: Eli Lilly And Company, Johnson & Johnson and Merck & Company, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 2,417 | US$2.67M | −202 | May 31, 2026 |
| Johnson & Johnson | 7,204 | US$1.62M | −153 | May 31, 2026 |
| Merck & Company, Inc. | 10,073 | US$1.2M | −842 | May 31, 2026 |
| Guardant Health, Inc. | 8,286 | US$1.07M | −692 | May 31, 2026 |
| Astrazeneca Plc | 5,234 | US$974K | −1,689 | May 31, 2026 |
| Thermo Fisher Scientific Inc | 1,847 | US$910K | −154 | May 31, 2026 |
| Argenx Se | 979 | US$818K | −82 | May 31, 2026 |
| Intuitive Surgical, Inc. | 1,849 | US$785K | −154 | May 31, 2026 |
| Boston Scientific Corporation | 15,740 | US$760K | −1,322 | May 31, 2026 |
| Hoya Corporation | 4,173 | US$710K | −350 | May 31, 2026 |